Source: Thailand Medical News Jan 23, 2020 4 years, 9 months, 4 weeks, 1 day, 13 hours, 13 minutes ago
Often, emerging
viral infections from bird flu to Ebola to Zika infections, pose major threats to global public health, and understanding their origins can help investigators design defensive strategies against future outbreaks.
A recent study provides important insights on the potential origins of the most recent outbreak of
viral pneumonia in
China, which started in the middle of December and now is spreading to Hong Kong, Singapore, Thailand, and Japan. The findings are published early online in the
Journal of Medical Virology.
The novel study notes that patients who became infected with the
virus which is a type of
virus called a
coronavirus and was named
2019-nCoV by the World Health Organization, were exposed to wildlife animals at a wholesale market, where seafood, poultry, snake, bats, and farm animals were sold.
By initiating a detailed genetic analysis of the
virus and comparing it with available genetic information on different
viruses from various geographic locations and host species, the investigators concluded that the
2019-nCoV appears to be a
virus that formed from a combination of a
coronavirus found in bats and another coronavirus of unknown origin. The resulting
virus developed a mix or "recombination" of a viral protein that recognizes and binds to receptors on host cells. Such recognition is key to allowing
viruses to enter host cells, which can lead to infection and disease.
In the last stages, the team uncovered evidence that the
2019-nCoV likely resided in
snakes before being transmitted to humans. Recombination within the viral receptor-binding protein may have allowed for cross-species transmission from snake to humans.
The researchers told
Thailand Medical News, "Results derived from our evolutionary analysis suggest for the first time that snake is the most probable wildlife animal reservoir for the
2019-nCoV virus. New information obtained from our evolutionary analysis is highly significant for effective control of the outbreak caused by the
2019-nCoV-induced
pneumonia."
Additionally, an accompanying editorial notes that although the ultimate control of emerging
viral infections requires the discovery and development of effective vaccines and/or antiviral drugs, currently licensed antiviral drugs should be tested against the
2019-nCoV
strong>.
(The market in Wuhan where the first virus outbreak was reported had many shops selling snakes. Chinese people literally eat anything and snakes are also a delicacy for them.)
References :
Wei Ji et al, Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross‐species transmission from snake to human,
Journal of Medical Virology (2020).
DOI: 10.1002/jmv.25682
Guangxiang (George) Luo et al. Global Health Concern Stirred by Emerging Viral Infections,
Journal of Medical Virology (2020).
DOI: 10.1002/jmv.25683